Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent progress the Government has made on funding (a) research and (b) trials on long-term vaccine efficacy for the immunocompromised after (a) first and (b) second dose.

As part of the National Core Studies Immunity Programme, UK Research and Innovation (UKRI) has provided initial funding of £1.8 million towards the OCTAVE study looking at COVID-19 vaccine responses in groups of immune suppressed individuals. UKRI is also supporting the Data and Connectivity National Core Studies programme with an investment of up to £8.2 million to date to enable the evaluation of vaccine uptake and efficacy across all populations.